article thumbnail

Top 3 Manufacturing and Packaging Articles of 2023

Pharmaceutical Commerce

Popular works in the category explore 340B guidelines, ‘smart pharma’ capabilities, and commercialization trends.

article thumbnail

Electronic smart packaging market to value nearly $3b in 2033

European Pharmaceutical Review

A market report has identified that global demand for electronic smart packaging will reach $2.6 percent from 2023, according to the data. Smart packaging has potential for the integration of electronic functionality, enabling compliance, material identification, condition monitoring and asset tracking of pharmaceutical products.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

September 2023 Newsletter

Safe Biologics

6 would prevent the HHS Secretary from requiring a switching study as part of the data package to receive the interchangeable designation. Register for the 2023 National Policy & Advocacy Summit on Biologics here. However, S.6 ASBM surveys of U.S. Read the new FDA’ Guidance here. Submit comments on the guidance here.

article thumbnail

October 2023 Newsletter

Safe Biologics

REMINDER: FDA Draft Guidance Would Remove Interchangeability Statement from Interchangeable Biosimilars Comments Due November 17th On September 15th, the Food and Drug Administration (FDA) released draft guidance removing the interchangeability statement from the product label/package insert. ASBM surveys of U.S. However, S.6

article thumbnail

Pharmapack Europe Awards 2023 winners announced

European Pharmaceutical Review

The winners of Pharmapack Europe’s 2023 awards have been announced, presented across a range of innovative recyclable packaging, drug delivery solutions, and reusable connected devices. The winner in the Eco-Design category was a high grade, 100 percent PET blister packaging.

article thumbnail

After 2022 interest rate hikes spook investors, pharma M&A to resurge in late 2023

Pharmaceutical Technology

Pharma company merger and acquisition (M&A) activity in the first half of 2023 has remained relatively low, consistent with the second half of last year, but investors predict deals will increase later in 2023. Experts at PWC, Goldman Sachs, and Morgan Stanley agree that pharma-related M&A is expected to pick up in 2023.

article thumbnail

Future-proofing the pharma cold chain

Express Pharma

So, in this article, we delve into this dynamic market to explore the driving factors behind its exponential growth and the trends shaping the market landscape while evaluating the pain points that need to be addressed for sustained growth. per cent from 2023 to 2033, compared to 13.3 billion in 2022. per cent during 2022-2028.

Packaging 114